+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Toxicity Testing Market By Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 231 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640267
Description Jump to:
The global in vitro toxicity testing market was valued at $18,565.2 million in 2020 and is projected to reach $59,147.6 million by 2030, growing at a CAGR of 12.0% from 2020 to 2030.

In vitro is the process of performing experiments in a test tube, culture dish, or outside a living organism. In vitro toxicity testing (IVTT) examines the effects of toxic chemical substances on cultured bacteria. It is used to identify hazardous chemical substances and helps detect the toxicity at early stages of the development of new products, such as drugs, cosmetics, and food additives. It is majorly used for safety evaluation in drug development and for ranking the chemicals according to their potency. Moreover, absorption, distribution, metabolism, and excretion (ADME), dose response, and threshold response of drugs are determined by this method.

The growth of the global in vitro toxicity testing market is driven by increase in acceptance by regulatory authorities for using this method for testing. Moreover, ban on animal testing and increase in awareness towards environmental concerns boost the market growth. However, factors such as reduction in adoption rate of in vitro toxicity testing kits and incapability of in vitro models to determine autoimmunity & immunostimulation restrain the market growth. Conversely, rise in focus towards new approaches of 3D cell culture and advancement in genetics & genetic screening approaches are expected to provide potential opportunities for market expansion.

The in vitro toxicity testing market is segmented into type, technology, end users, and region. On the basis of type, the market is categorized into absorption, toxic substances, and dose. Currently, the absorption segment dominates the global in vitro toxicity testing market.

On the basis of end user, the market is categorized into pharmaceuticals, cosmetics & household products, chemicals industry, and food industry. The cosmetics and households products segment is dominant among end users, followed by the pharmaceutical industry. On the basis of technology, the in vitro toxicity testing market is segmented in to cell culture technologies, high throughput technologies, and toxicogenomics. The cell culture technologies segment generated the highest revenue in 2020.

On the basis of region, the in vitro toxicity testing market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is the highest revenue growth, followed by Europe. LAMEA is predicted to grow faster than Asia-Pacific with a CAGR of 16.7% during the forecast period. The LAMEA segment is expected to dominate the in vitro toxicity testing market.

The key players operating in the market include, Acacia Pharma Group Plc., AstraZeneca Plc, GlaxoSmithKline Plc, Helsinn Holdings S.A., Heron Therapeutics Inc., Inc., General Electric Company, EISAI Pharmaceutical Pvt Ltd., Catalent, Inc., Laboratory Corporation of America Holdings., and Thermo Fisher Scientific, Inc.

Major players, such as GlaxoSmithKline Plc (GSK), General Electric Company, AstraZeneca Plc, and others are adopting the acquisition strategy to improve their product portfolio to maintain competition in the market. For instance, AstraZeneca completed the acquisition of Alexion pharmaceuticals, Inc. in July 2021. This acquisition aims to enhance scientific presence in immunology and through Alexion's innovative complement-biology platform and robust pipeline, and is expected to continue to pioneer the discovery and development of medicines for patients with rare diseases. Such instances are expected to provide lucrative opportunities for the major players for the growth of the market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the in vitro toxicology industry segments, current trends, estimations, and dynamics of the in vitro toxicity testing market analysis from 2020 to 2030 to identify the prevailing in vitro toxicity testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the in vitro toxicity testing market segmentation, and in vitro toxicity testing market forecast assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global in vitro toxicity testing industry.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global in vitro toxicity testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Type

  • Absorption
  • Toxic Substances
  • Dose

By Technology

  • Cell Culture Technologies
  • High Throughput Technologies
  • Toxicogenomics

By End User

  • Cosmetics and Households Products
  • Pharmaceuticals Industry
  • Food Industry
  • Chemicals Industry

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest Of Asia Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • General Electric Company
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings
  • ACACIA PHARMA GROUP PLC
  • TESARO INC.
  • Helsinn Holding S.A.
  • Heron Therapeutics Inc
  • AstraZeneca plc
  • Catalent Inc

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: IN VITRO TOXICITY TESTING MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Absorption
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Toxic Substances
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Dose
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: IN VITRO TOXICITY TESTING MARKET, BY TECHNIOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Cell Culture Technologies
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 High Throughput Technologies
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Toxicogenomics
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: IN VITRO TOXICITY TESTING MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Cosmetics and Households Products
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Pharmaceuticals Industry
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Food Industry
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Chemicals Industry
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: IN VITRO TOXICITY TESTING MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Techniology
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Techniology
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Techniology
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Techniology
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Techniology
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Techniology
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 Italy
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Techniology
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Techniology
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Techniology
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Rest of Europe
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Techniology
7.3.5.5.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Techniology
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Techniology
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Techniology
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Techniology
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Techniology
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest Of Asia Pacific
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Techniology
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Techniology
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Latin America
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Techniology
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Middle East
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Techniology
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Techniology
7.5.5.3.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 General Electric Company
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Laboratory Corporation of America Holdings
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 ACACIA PHARMA GROUP PLC
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 TESARO INC.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Helsinn Holding S.A.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Heron Therapeutics Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 AstraZeneca plc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Catalent Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global in Vitro Toxicity Testing Market, by Type, 2020-2030, ($Million)
Table 2. in Vitro Toxicity Testing Market Revenue, for Absorption, by Region, 2020-2030, ($Million)
Table 3. in Vitro Toxicity Testing Market Absorption by Country, 2020-2030, ($Million)
Table 4. in Vitro Toxicity Testing Market Revenue, for Toxic Substances, by Region, 2020-2030, ($Million)
Table 5. in Vitro Toxicity Testing Market Toxic Substances by Country, 2020-2030, ($Million)
Table 6. in Vitro Toxicity Testing Market Revenue, for Dose, by Region, 2020-2030, ($Million)
Table 7. in Vitro Toxicity Testing Market Dose by Country, 2020-2030, ($Million)
Table 8. Global in Vitro Toxicity Testing Market, by Techniology, 2020-2030, ($Million)
Table 9. in Vitro Toxicity Testing Market Revenue, for Cell Culture Technologies, by Region, 2020-2030, ($Million)
Table 10. in Vitro Toxicity Testing Market Cell Culture Technologies by Country, 2020-2030, ($Million)
Table 11. in Vitro Toxicity Testing Market Revenue, for High Throughput Technologies, by Region, 2020-2030, ($Million)
Table 12. in Vitro Toxicity Testing Market High Throughput Technologies by Country, 2020-2030, ($Million)
Table 13. in Vitro Toxicity Testing Market Revenue, for Toxicogenomics, by Region, 2020-2030, ($Million)
Table 14. in Vitro Toxicity Testing Market Toxicogenomics by Country, 2020-2030, ($Million)
Table 15. Global in Vitro Toxicity Testing Market, by End-user, 2020-2030, ($Million)
Table 16. in Vitro Toxicity Testing Market Revenue, for Cosmetics and Households Products, by Region, 2020-2030, ($Million)
Table 17. in Vitro Toxicity Testing Market Cosmetics and Households Products by Country, 2020-2030, ($Million)
Table 18. in Vitro Toxicity Testing Market Revenue, for Pharmaceuticals Industry, by Region, 2020-2030, ($Million)
Table 19. in Vitro Toxicity Testing Market Pharmaceuticals Industry by Country, 2020-2030, ($Million)
Table 20. in Vitro Toxicity Testing Market Revenue, for Food Industry, by Region, 2020-2030, ($Million)
Table 21. in Vitro Toxicity Testing Market Food Industry by Country, 2020-2030, ($Million)
Table 22. in Vitro Toxicity Testing Market Revenue, for Chemicals Industry, by Region, 2020-2030, ($Million)
Table 23. in Vitro Toxicity Testing Market Chemicals Industry by Country, 2020-2030, ($Million)
Table 24. in Vitro Toxicity Testing Market, by Region, 2020-2030, ($Million)
Table 25. North America in Vitro Toxicity Testing Market, by Type, 2020-2030, ($Million)
Table 26. North America in Vitro Toxicity Testing Market, by Techniology, 2020-2030, ($Million)
Table 27. North America in Vitro Toxicity Testing Market, by End-user, 2020-2030, ($Million)
Table 28. North America in Vitro Toxicity Testing Market, by Country, 2020-2030, ($Million)
Table 29. U.S. in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 30. U.S. in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 31. U.S. in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 32. Canada in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 33. Canada in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 34. Canada in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 35. Mexico in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 36. Mexico in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 37. Mexico in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 38. Europe in Vitro Toxicity Testing Market, by Type, 2020-2030, ($Million)
Table 39. Europe in Vitro Toxicity Testing Market, by Techniology, 2020-2030, ($Million)
Table 40. Europe in Vitro Toxicity Testing Market, by End-user, 2020-2030, ($Million)
Table 41. Europe in Vitro Toxicity Testing Market, by Country, 2020-2030, ($Million)
Table 42. Germany in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 43. Germany in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 44. Germany in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 45. Italy in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 46. Italy in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 47. Italy in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 48. France in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 49. France in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 50. France in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 51. Spain in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 52. Spain in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 53. Spain in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 54. Rest of Europe in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 55. Rest of Europe in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 56. Rest of Europe in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 57. Asia-Pacific in Vitro Toxicity Testing Market, by Type, 2020-2030, ($Million)
Table 58. Asia-Pacific in Vitro Toxicity Testing Market, by Techniology, 2020-2030, ($Million)
Table 59. Asia-Pacific in Vitro Toxicity Testing Market, by End-user, 2020-2030, ($Million)
Table 60. Asia-Pacific in Vitro Toxicity Testing Market, by Country, 2020-2030, ($Million)
Table 61. China in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 62. China in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 63. China in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 64. Japan in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 65. Japan in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 66. Japan in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 67. India in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 68. India in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 69. India in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 70. South Korea in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 71. South Korea in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 72. South Korea in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 73. Rest of Asia-Pacific in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 74. Rest of Asia-Pacific in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 75. Rest of Asia-Pacific in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 76. LAMEA in Vitro Toxicity Testing Market, by Type, 2020-2030, ($Million)
Table 77. LAMEA in Vitro Toxicity Testing Market, by Techniology, 2020-2030, ($Million)
Table 78. LAMEA in Vitro Toxicity Testing Market, by End-user, 2020-2030, ($Million)
Table 79. LAMEA in Vitro Toxicity Testing Market, by Country, 2020-2030, ($Million)
Table 80. Latin America in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 81. Latin America in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 82. Latin America in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 83. Middle East in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 84. Middle East in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 85. Middle East in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 86. Africa in Vitro Toxicity Testing Market by Type 2020-2030, ($Million)
Table 87. Africa in Vitro Toxicity Testing Market by Techniology 2020-2030, ($Million)
Table 88. Africa in Vitro Toxicity Testing Market by End-user 2020-2030, ($Million)
Table 89. General Electric Company: Company Snapshot
Table 90. General Electric Company: Operating Segments
Table 91. General Electric Company: Product Portfolio
Table 92. General Electric Company: Net Sales
Table 93. General Electric Company: Key Stratergies
Table 94. Thermo Fisher Scientific, Inc.: Company Snapshot
Table 95. Thermo Fisher Scientific, Inc.: Operating Segments
Table 96. Thermo Fisher Scientific, Inc.: Product Portfolio
Table 97. Thermo Fisher Scientific, Inc.: Net Sales
Table 98. Thermo Fisher Scientific, Inc.: Key Stratergies
Table 99. Laboratory Corporation of America Holdings: Company Snapshot
Table 100. Laboratory Corporation of America Holdings: Operating Segments
Table 101. Laboratory Corporation of America Holdings: Product Portfolio
Table 102. Laboratory Corporation of America Holdings: Net Sales
Table 103. Laboratory Corporation of America Holdings: Key Stratergies
Table 104. Acacia Pharma Group plc: Company Snapshot
Table 105. Acacia Pharma Group plc: Operating Segments
Table 106. Acacia Pharma Group plc: Product Portfolio
Table 107. Acacia Pharma Group plc: Net Sales
Table 108. Acacia Pharma Group plc: Key Stratergies
Table 109. Tesaro Inc.: Company Snapshot
Table 110. Tesaro Inc.: Operating Segments
Table 111. Tesaro Inc.: Product Portfolio
Table 112. Tesaro Inc.: Net Sales
Table 113. Tesaro Inc.: Key Stratergies
Table 114. Helsinn Holding S.A.: Company Snapshot
Table 115. Helsinn Holding S.A.: Operating Segments
Table 116. Helsinn Holding S.A.: Product Portfolio
Table 117. Helsinn Holding S.A.: Net Sales
Table 118. Helsinn Holding S.A.: Key Stratergies
Table 119. Heron Therapeutics Inc: Company Snapshot
Table 120. Heron Therapeutics Inc: Operating Segments
Table 121. Heron Therapeutics Inc: Product Portfolio
Table 122. Heron Therapeutics Inc: Net Sales
Table 123. Heron Therapeutics Inc: Key Stratergies
Table 124. Astrazeneca plc: Company Snapshot
Table 125. Astrazeneca plc: Operating Segments
Table 126. Astrazeneca plc: Product Portfolio
Table 127. Astrazeneca plc: Net Sales
Table 128. Astrazeneca plc: Key Stratergies
Table 129. Catalent Inc: Company Snapshot
Table 130. Catalent Inc: Operating Segments
Table 131. Catalent Inc: Product Portfolio
Table 132. Catalent Inc: Net Sales
Table 133. Catalent Inc: Key Stratergies
LIST OF FIGURES
Figure 1. In Vitro Toxicity Testing Market Segmentation
Figure 2. In Vitro Toxicity Testing Market, 2020-2030
Figure 3. In Vitro Toxicity Testing Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. In Vitro Toxicity Testing Market:Drivers, Restraints and Opportunities
Figure 11. In Vitro Toxicity Testing Market, by Type, 2020 (%)
Figure 12. Comparative Share Analysis of Absorption in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Toxic Substances in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Dose in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 15. In Vitro Toxicity Testing Market, by Techniology, 2020 (%)
Figure 16. Comparative Share Analysis of Cell Culture Technologies in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of High Throughput Technologies in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Toxicogenomics in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 19. In Vitro Toxicity Testing Market, by End-user, 2020 (%)
Figure 20. Comparative Share Analysis of Cosmetics and Households Products in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 21. Comparative Share Analysis of Pharmaceuticals Industry in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 22. Comparative Share Analysis of Food Industry in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of Chemicals Industry in Vitro Toxicity Testing Market, 2020-2030 (%)
Figure 24. In Vitro Toxicity Testing Market by Region, 2020
Figure 25. U.S. in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 26. Canada in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 27. Mexico in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 28. Germany in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 29. Italy in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 30. France in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 31. Spain in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 32. Rest of Europe in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 33. China in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 34. Japan in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 35. India in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 36. South Korea in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 37. Rest of Asia-Pacific in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 38. Latin America in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 39. Middle East in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 40. Africa in Vitro Toxicity Testing Market, 2020-2030 ($Million)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap of Top 10 Key Players
Figure 47. General Electric Company.: Net Sales, ($Million)
Figure 48. Thermo Fisher Scientific, Inc. Net Sales, ($Million)
Figure 49. Laboratory Corporation of America Holdings.: Net Sales, ($Million)
Figure 50. Acacia Pharma Group PLC.: Net Sales, ($Million)
Figure 51. Tesaro Inc. Net Sales, ($Million)
Figure 52. Helsinn Holding SA.: Net Sales, ($Million)
Figure 53. Heron Therapeutics Inc.: Net Sales, ($Million)
Figure 54. Astrazeneca PLC.: Net Sales, ($Million)
Figure 55. Catalent Inc.: Net Sales, ($Million)

Executive Summary

The in vitro toxicity testing market size was valued at $18.6 billion in 2020, and is estimated to reach $58.9 billion by 2030, growing at a CAGR of 12% from 2021 to 2030.
In vitro toxicity testing market size is expected to witness notable growth in the coming years due to the advantages offered by IVTT, such as enhanced accuracy, efficiency, and reliability as compared to other traditional methods. Furthermore, increase in applications of IVTT in food and chemical industries, are the in vitro toxicity testing market trends. Moreover, stringent government regulations aimed at reducing the cruelty while performing experiment on animals, increase illicit drug abuse, and enhanced efficiency of IVTT in diagnosis are the major driving factors for the growth of the market. The impact of these drivers is expected to increase significantly due to increase in awareness about the benefits of IVTT. Some of the restraints associated with the IVTT market are decrease adoption rate of IVTT and incapability of IVTT to detect toxicities due to autoimmunity & immunostimulation. With the advancement in the technology, the challenges of IVTT are expected to reduce in the coming years. A rise in need for testing in various industries such as pharmaceuticals, food, and others, which drives the growth of the in vitro toxicology testing market.

The in vitro toxicology testing market is segmented into type, technology, end users, and region. By type, the market is categorized into absorption, toxic substances, and dose. Currently, the absorption segment dominates the global in vitro toxicity testing market growth.

On the basis of end users, the market is categorized into pharmaceuticals, cosmetics & household products, chemicals industry, and food industry. The cosmetics and households products segment is dominant among end users, followed by the pharmaceutical industry.

On the basis of technology, the in vitro toxicity testing market is segmented into cell culture technologies, high throughput technologies, and toxicogenomics. The cell culture technologies have the highest in vitro toxicity testing market share in 2020.

On the basis of region, the in vitro toxicity testing market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is the highest revenue growth, followed by Europe. LAMEA is predicted to grow faster than Asia-Pacific with a CAGR of 16.7% during the forecast period. The LAMEA segment is expected to dominate the in vitro toxicity testing market.

The key players operating in this market include, Acacia Pharma Group Plc., AstraZeneca Plc, GlaxoSmithKline Plc, Helsinn Holdings S.A., Heron Therapeutics Inc., Inc., General Electric Company, EISAI Pharmaceutical Pvt Ltd., Catalent, Inc., Laboratory Corporation of America Holdings., and Thermo Fisher Scientific, Inc.

Major players are adopting product launch and acquisition as key developmental strategies to improve the product portfolio of warehouse robots. For instance, in April 2019, Thermo Fisher acquired Brammer Bio for approximately $1.67 billion in cash. Brammer Bio is a leading viral vector contract development and manufacturing for company for gene and cell therapies.

Several manufacturers in the global in vitro toxicity testing market stopped their business activities in 2020 due to lockdowns implemented in developed and developing countries, owing to ban on industrial activities due to the COVID-19 pandemic. This halt in production activities impacted the revenue of the in vitro toxicity testing manufacturing companies. For instance, net sales of General Electric Company dropped by 2.2% from January 2021 to December 2021. In addition, lack of man power and raw materials affected the supply chain of the global in vitro toxicity testing market. However, the market is projected to cover from the 1st quarter of 2023, due to reduced restrictions and reopening of the global in vitro toxicity testing industry. Moreover, in 2021, with the availability of vaccine against COVID-19, the in vitro toxicology industry re-opened at full pace with a start of 2022.

KEY FINDINGS OF STUDY

  • The report provides an extensive analysis of the current and emerging global in vitro toxicity testing market trends and dynamics.
  • By type, the absorption segment dominated the market in terms of revenue in 2020.
  • On the basis of technology, the cell culture technologies segment generated the highest revenue in 2020.
  • By end-user, the cosmetics and households products segment dominated the market in terms of revenue in 2020.
  • The report provides an extensive analysis of the trends and emerging opportunities of the market.
  • In depth, the global in vitro toxicity testing market analysis is conducted by constructing estimations for the key segments between 2020 and 2030.

Companies Mentioned

  • General Electric Company
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings
  • ACACIA PHARMA GROUP PLC
  • TESARO INC.
  • Helsinn Holding S.A.
  • Heron Therapeutics Inc
  • AstraZeneca plc
  • Catalent Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages231
PublishedMarch 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 18565.2 million
Forecasted Market Value ( USD ) by 2030 $ 59147.6 million
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

In Vitro Toxicity Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

In Vitro Toxicity Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
In-Vitro Toxicity Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

In-Vitro Toxicity Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 95 Pages
  • Global
From
in-vitro Toxicology Testing Market Size, Share & Trends Analysis Report by Technology (Cell Culture, High Throughput), End-use, Application, Method (Cellular Assay), Product, Region, and Segment Forecasts, 2024-2030 - Product Image

in-vitro Toxicology Testing Market Size, Share & Trends Analysis Report by Technology (Cell Culture, High Throughput), End-use, Application, Method (Cellular Assay), Product, Region, and Segment Forecasts, 2024-2030

  • Report
  • 117 Pages
  • Global
From
In-Vitro Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031 - Product Image

In-Vitro Toxicology Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • Report
  • 111 Pages
  • Global
From
In-Vitro Toxicology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

In-Vitro Toxicology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.